<DOC>
	<DOCNO>NCT00867191</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy ( % change baseline ) desloratadine improve nasal total symptom score SAR cypress pollen .</brief_summary>
	<brief_title>Comparison Effects Desloratadine Placebo Relief Nasal Symptom Scores Subjects With Seasonal Allergic Rhinitis Cypress Pollen ( Study P02836 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Patients must demonstrate willingness participate study comply procedure sign write informed consent . Patients must &gt; =18 year age , either gender . Women childbearing potential ( include woman less 1 year postmenopausal woman become sexually active ) must use agree use acceptable method birth control ( e.g . hormonal contraceptive , medically prescribe intrauterine device , condom combination spermicide ) surgically sterilize ( e.g . hysterectomy tubal ligation ) . Women childbearing potential currently sexually active must agree consent use one abovementioned method , become sexually active participate study . Patients must good general health ; i.e. , must free clinically significant disease ( SAR cypress pollen ) could interfere study evaluation . Patients must understand able adhere measurement , dose visit schedule , agree report concomitant medication adverse event investigator designee . Patients must least twoyear history ( selfreported acceptable ) intermittent allergic rhinitis specifically January March Patients must clinically symptomatic SAR cypress pollen Visit 2 ( Day 0 ) : total ( nasal + nonnasal ) symptom score must &gt; =8 nasal congestion score &gt; =2 . Patients may reschedule two additional time qualify visit meet minimum symptom score A positive skin prick test / positive cypressspecific IgE RAST ( &gt; = class 2 ) . These test perform within 24 month Visit 1 Women childbearing potential must negative urine pregnancy test Visit 2 ( Day 0 ) . Women pregnant nursing . Patients observe designate washout period prohibit medication . Patients rhinitis medicamentosa . Patients upper respiratory tract sinus infection require antibiotic therapy within 14 day prior Visit 1 ( screen / consent ) patient viral upper respiratory infection within 7 day prior Visit 2 . Patients nasal structural abnormality , include nasal polyp mark septal deviation , interfere significantly nasal airflow . Patients history hypersensitivity desloratadine excipients . Patients staff personnel directly involve administration study . Patients previously randomise study . Patients used investigational drug last 30 day prior Visit 1 . Patients current evidence clinically significant haematopoietic , metabolic , cardiovascular , immunological , neurological , haematological , gastrointestinal , hepatic , renal , psychiatric , cerebrovascular respiratory disease , disorder , judgment investigator , may interfere study evaluation affect patient safety .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>